We provide translational data in primary CD34+ progenitors from AML patients showing IL-1RN deregulation in newly diagnosed AML patients, particularly those with lower differentiation profiles, making the study of the prognostic value of IL-1RN not possible in this group. This evidence concerns the gene CD34 and acute myeloid leukemia.